Skip to content

H2020HORIZON

St. Anna Kinderkrebsforschung GmbH

Country
ATAustria
Defence projects
0
Projects, all programmes
19
As coordinator
5
EU contribution (CORDIS)
EUR 9,486,636
Active
2016 to 2024

Projects

19 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCEHORIZON2024ParticipantEUR 153,675
EngineeringSARCOMAsBuilding models of fusion-driven sarcomas via cell fate engineeringHORIZON2024CoordinatorEUR 183,601
MONALISAA SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive AnalysisHORIZON2024ParticipantEUR 1,206,528
Maxima ButterflyFrom Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology networkHORIZON2023Associated partnerEUR 0
IntReALL 2020International Study for Treatment of Childhood Relapsed ALL 2020HORIZON2023ParticipantEUR 121,250
SARCOMAkidsDevelopmentally programmed pediatric sarcomas: a versatile platform for drug discovery and molecular precision medicineHORIZON2023CoordinatorEUR 1,999,124
B-ALLelesHigh resolution dissection of non-coding determinants of diseaseHORIZON2022CoordinatorEUR 183,601
FIND-seqFunctional Interrogation of Non-coding DNA Sequences in leukemia development and drug resistanceH20202021CoordinatorEUR 1,784,000
PanCareSurPassPanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivorsH20202021ParticipantEUR 358,750
ERICAEuropean Rare dIsease research Coordination and support ActionH20202021ParticipantEUR 212,125
TRELTwinning in Research and Education to improve survival in Childhood Solid Tumours in LithuaniaH20202021ParticipantEUR 47,390
VAGABONDValidation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate studentsH20202020ParticipantEUR 264,207
Instand-NGS4PIntegrated and standardized NGS workflows for Personalised therapyH20202020ParticipantEUR 316,953
iDysChartCharting key molecules and mechanisms of human immune DysregulationH20202019CoordinatorEUR 1,241,971
CLOSERChildhood Leukemia: Overcoming distance between South America and Europe RegionsH20202019ParticipantEUR 408,588
EJP RDEuropean Joint Programme on Rare DiseasesH20202019ParticipantEUR 81,813
PRIMAGEPRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkersH20202018ParticipantEUR 842,512
ITCC-P4ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064H20202017ParticipantEUR 60,474
ChiLTERNChildren’s Liver Tumour European Research NetworkH20202016ParticipantEUR 20,075

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.